Early discovery is essential for cardiovascular conditions like Peripheral Arterial Disease (PAD), but has largely been inaccessible at primary care level. Traditional ways of Ankle-Brachial Index (ABI) measurement like Doppler are highly specialized and are performed exclusively in secondary care, usually when the symptoms already indicate a health problem. Since many PAD patients are asymptomatic, the latest PAD guidelines urge ABI measurement for all risk groups at primary care level. Digital devices like MESI’s enable ABI and TBI check-ups in a matter of minutes.
In this blog you will learn:
According to the latest international guidelines on Peripheral Arterial Disease (PAD), it is essential to discover it in the early stage. The aim is to prevent its dangerous outcomes such as heart attack, stroke, ulceration, or amputation. Since nearly 70% of PAD patients are asymptomatic, however, this calls for systematic prevention efforts.
The current guidelines recommend PAD screening in primary care, using the Ankle-Brachial Index (ABI) in all patients with cardiovascular risks. This is largely still not implemented due to the limitations of the traditional measurement methods.
ABI measurements with standard devices like the handheld Doppler probe are time-consuming and require trained operators (i.e. specialised staff). This makes systematic PAD detection and preventive check-ups inaccessible at primary care level.
At MESI, we fill this gap by offering doctors and nurses easy-to-use and fast solutions in the field of basic diagnostics, with 1-minute ABI and TBI measurements at the forefront.
The MESI mTABLET ABI can come as a smart stand-alone solution or as part of a modular system for collecting all basic diagnostic measurements. It is easily expandable with additional digital modules, such as TBI, ECG, spirometry and oximetry.
All the measurements are instantly stored into the patient’s electronic record (MESI mRECORDS) and are accessible or shareable at any time. This means less paperwork, a faster diagnosis and more time for your patients.
The MESI ABPI MD is an easy-to-use tool for simple, repeatable and reliable ABI measurement. It was actually our very first diagnostic innovation back in 2014. Since then, 1-minute arterial assessment has brought us to more than 50 countries worldwide.
Both solutions excel at fast ABI measurement, taking no more than 1 minute. This is significantly less time (total measurement procedure can be done in a few minutes) than with traditional methods, which can take up to 30 minutes and represent an important tool in combating PAD at primary care level and beyond.
They enable early detection of Peripheral Arterial Disease in general practices, cardiology, vascular surgery, compression therapy and wound care, nephrology, angiology, diabetology, neurology, and orthopaedic surgery. A detailed comparison between the two solutions is provided below.